🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To test the feasibility of an intensive behavioral and pharmacologic tobacc...
Status
Completed
Location
Indiana University, Department of Radiation Oncology
Start Date
2005-10
Trial ID
NCT00236288
Treatments Being Tested
Smoking is the leading cause of preventable illness, disability, and death ...
Status
Completed
Location
Durham VA Medical Center, Durham, NC
Start Date
2019-11-07
Trial ID
NCT03978442
The goal of this research study is to examine the effects of a treatment fo...
Status
Completed
Location
Durham VA Medical Center, Durham, NC
Start Date
2014-10-01
Trial ID
NCT02245308
This project proposes to evaluate the feasibility, acceptability, and effic...
Status
Completed
Location
Duke University Medical Center
Start Date
2017-01
Trial ID
NCT02873754
People living with HIV (PLHIV) have higher rates of tobacco use than the ge...
Status
Completed
Location
Kenya Medical Research Institute (KEMRI)
Start Date
2023-05-16
Trial ID
NCT05351606
Treatments Being Tested
This study recruited cigarette smokers under supervision in community corre...
Status
Completed
Location
UAB Substance Abuse
Start Date
2009-10
Trial ID
NCT01257490
Treatments Being Tested
The purpose of this study is to determine whether a combination of naltrexo...
Status
Completed
Location
University of California, San Diego: Dept of Family & Preventive Medicine
Start Date
2007-03
Trial ID
NCT00456521
There are currently over 11 million cancer survivors in the U.S. and surviv...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-09
Trial ID
NCT01871506
Treatments Being Tested
Contrave (naltrexone HCl and bupropion HCl) extended-release tablet is an a...
Status
Unknown
Location
Guelph General Hospital
Start Date
2021-02-01
Trial ID
NCT04589130
Treatments Being Tested